Henry Ford Health

HAP Ranked No. 1 in Michigan for Commercial Health Plan Member Satisfaction by J.D. Power

Retrieved on: 
Thursday, June 1, 2023
J.D. Power, Communication, HAP, Henry Ford Health, Health insurance

DETROIT, June 1, 2023 /PRNewswire/ -- Health Alliance Plan (HAP), a Michigan-based, nonprofit health plan, ranks No. 1 in member satisfaction among commercial health plans in Michigan, according to the J.D. Power 2023 U.S. Commercial Member Health Plan Study.

Key Points: 
  • DETROIT, June 1, 2023 /PRNewswire/ -- Health Alliance Plan (HAP), a Michigan-based, nonprofit health plan, ranks No.
  • 1 in member satisfaction among commercial health plans in Michigan, according to the J.D.
  • Power 2023 U.S. Commercial Member Health Plan Study.
  • Power U.S. Commercial Member Health Plan Study measures satisfaction among nearly 32,449 members of 150 health plans in 22 regions throughout the country.

BIO 300 Enhances Radiotherapy Efficacy Against Lung Tumors in a Nonclinical Model

Retrieved on: 
Wednesday, May 24, 2023
Men, General Health, Science, Family, Consumer, Clinical Trials, COVID-19, Health, Other Science, Research, Other Health, Other Consumer, Radiology, Women, Pharmaceutical, Seniors, Oncology, BIO, AME Publishing Company, Radiation, Neoplasm, Lung, Policy, Clinical trial, Cancer, Lung cancer, Henry Ford Health, Quality of life, Humanetics, Lung tumor, Patient, Risk, Collateral damage, Medical imaging

The positive results showcased that BIO 300 can protect normal tissues from collateral damage associated with radiotherapy without protecting the lung tumor, while potentially sensitizing the tumors to radiotherapy.

Key Points: 
  • The positive results showcased that BIO 300 can protect normal tissues from collateral damage associated with radiotherapy without protecting the lung tumor, while potentially sensitizing the tumors to radiotherapy.
  • The studies compared the effect of radiotherapy, with and without BIO 300 dosing, on normal tissue and tumors.
  • The researchers concluded that BIO 300 was radioprotective of normal lung tissue without compromising the efficacy of radiotherapy on lung tumors.
  • The drug appeared to sensitize lung tumors to radiotherapy, suggesting a role in enhancing the therapeutic efficacy of radiotherapy.

Parsley Health Launches Comprehensive Women’s Health Program for Employers

Retrieved on: 
Thursday, May 18, 2023
Alternative Medicine, Health, Consumer, Telemedicine, Virtual Medicine, Women, General Health, Workforce, Communication, Executive, Partnership, Life, Frontiers, Absenteeism, Henry Ford Health, Woman, NPS, Digital health, Root cause analysis, Menopause, Disease, Conditional sentence, Diagnosis, Patient, ROI, GI, Autoimmunity, Health insurance, Birth control, Parsley

Parsley Health, a provider of advanced primary care and specialized medical programs for women and families with complex health needs, today announced the launch of a women’s full continuum of care program for employers.

Key Points: 
  • Parsley Health, a provider of advanced primary care and specialized medical programs for women and families with complex health needs, today announced the launch of a women’s full continuum of care program for employers.
  • Patients in the program receive coordinated medical care and health coaching designed to support their whole health needs from a single virtual homebase.
  • The program comprehensively addresses common chronic conditions and comorbidities, including autoimmune, GI, cardiometabolic, behavioral health, and hormonal conditions – and supports women end-to-end, from the moment they start thinking about their reproductive health to menopause.
  • “The quintessential workforce age woman needs comprehensive care that spans each phase of her life and supports her beyond her reproductive health goals.

CodaMetrix Autonomous Bedside Pro Medical Coding Launches with Henry Ford Health

Retrieved on: 
Thursday, May 18, 2023
Workforce, Interim, Partnership, University, Bed, Workflow, Stroke, Hospital, Pathology, Booth, Splenic infarction, Oregon Health & Science University, Autonomy, Henry Ford Health, Radiology, Documentation, Henry Ford, Patient, Mass, Physician, SUNY Downstate Health Sciences University, Mass General Brigham, Burns, GI, Conference, Injury, Nursing

Henry Ford Health , one of the nation's leading nonprofit academic medical institutions, is a customer and collaborator.

Key Points: 
  • Henry Ford Health , one of the nation's leading nonprofit academic medical institutions, is a customer and collaborator.
  • The partnership will empower the revenue cycle team at Henry Ford Health to utilize AI-powered autonomous coding for their more than 700,000 bedside services provided each year, reducing physician, medical coding, and billing administrative burden, and driving more financial and operational efficiency.
  • The expansion into bedside professional coding with Henry Ford Health System highlights CodaMetrix's breadth and depth of capabilities, which drive increased efficiency across the entire healthcare enterprise.
  • "We are thrilled to work with an innovative partner like Henry Ford Health System to extend our autonomous coding platform for complex use cases, such as inpatient bedside visits."

NIH STUDY INVESTIGATES FACTORS AFFECTING ASTHMA WITH FREQUENT SYMPTOM FLARE UPS IN YOUNG CHILDREN

Retrieved on: 
Wednesday, May 10, 2023
Asthma, Icahn School of Medicine at Mount Sinai, Incidence rate (market research), ECHO, Henry Ford Health, Research, Risk, Mount Sinai, Bangladesh Technical Education Board, Incidence, MD, DOI, Biophysical environment, ARE, MPH, Pharmaceutical industry, Birth control, Doctor of Philosophy

During this study, ECHO researchers looked at data from over 17,000 children between 1990 and 2017 from across the U.S. including Puerto Rico in order to learn which factors influenced the rates of childhood ARE—a subtype of asthma where children experience frequent, severe episodes of asthma.

Key Points: 
  • During this study, ECHO researchers looked at data from over 17,000 children between 1990 and 2017 from across the U.S. including Puerto Rico in order to learn which factors influenced the rates of childhood ARE—a subtype of asthma where children experience frequent, severe episodes of asthma.
  • They found that non-Hispanic Black and Hispanic Black children, children ages 2 to 4 years old, and children who lived in the Northeast and Midwest had the highest rates of ARE.
  • These findings suggest that different environmental and social factors may play a significant role in the onset of recurring asthma issues in children.
  • Incidence Rates of Childhood Asthma with Recurrent Exacerbations in the U.S. Environmental influences on Child Health Outcomes (ECHO) Program.

Industry Leaders Align to Launch virtualnursing.com as the Thought Leadership Hub for Virtual Nursing Innovation

Retrieved on: 
Monday, May 1, 2023
Workforce, Steering Committee for Humanitarian Response, University, Q&A, Geisinger, EVP, Vanderbilt University School of Nursing, Innovation, Henry Ford Health, Microsoft, MBA, HIMSS, CommonSpirit Health, MS, Committee, Henry Ford, Digital transformation, MSA, MA, RN, Patient safety, Research, MPH, SVP, FAAN, Safety, Dean (education), Pharmaceutical industry, Nursing

ORLANDO, Fla., May 1, 2023 /PRNewswire/ -- As the Steering and Editorial Committee, we are thrilled to announce the launch of virtualnursing.com, the ultimate destination for thought-provoking insights, peer connections and collaboration to understand the trends and best practices that will revolutionize the nursing landscape.

Key Points: 
  • The no-cost website features a wealth of resources, including curated articles and podcasts focused on virtual nursing created by respected industry sources.
  • This content is written, sourced, and led by top experts and thought leaders in the field of virtual nursing.
  • "Virtualnursing.com has already attracted engagement and commitment from nursing leaders to share and align with peers from across the country."
  • To learn more about how clinicians are implementing and facilitating discussions around virtual nursing, visit virtualnursing.com and follow virtualnursing.com on Twitter and LinkedIn .

CancerIQ Adds Dr. Carladenise Edwards to Board of Directors

Retrieved on: 
Tuesday, April 18, 2023
Sociology, University, Providence St. Joseph Health, Education, Woman, Henry Ford Health, Pharmacy, Falls, Doctor of Philosophy, Government, Clover Health, Alameda Health System, Series, Management, Pharmaceutical industry, Nursing

CHICAGO, April 18, 2023 /PRNewswire-PRWeb/ -- CancerIQ, the platform powering early cancer detection and prevention across broad patient populations, today announced Carladenise Edwards, PhD, a dedicated leader with more than three decades of experience in healthcare, government and technology, as the newest member of its board of directors.

Key Points: 
  • CHICAGO, April 18, 2023 /PRNewswire-PRWeb/ -- CancerIQ , the platform powering early cancer detection and prevention across broad patient populations, today announced Carladenise Edwards, PhD, a dedicated leader with more than three decades of experience in healthcare, government and technology, as the newest member of its board of directors.
  • "Carladenise's firsthand experience delivering results and exceeding growth targets for large health systems makes her an invaluable addition to CancerIQ's board," said Feyi Ayodele, CEO and co-founder of CancerIQ.
  • Transitioning away from the health system C-suite, Dr. Edwards now serves as strategic advisor and board member for well-established healthcare companies such as Clover Health and Heluna Health.
  • Dr. Edwards adds health system experience to a board already made up of members with diverse professional backgrounds, including experts in pharmacy, IT, investing, and life sciences.

Illumina and Henry Ford Health team up to study impact of comprehensive genomic testing for cardiovascular patients

Retrieved on: 
Monday, November 13, 2023
DNA, Partnership, Cardiovascular disease, Education, Genomics, Clinical Pharmacogenetics Implementation Consortium, Personalized medicine, Henry Ford Health, Food and Drug Administration, Genetic distance, Individualized medicine, Lisa, Pharmacist, Henry Ford, Patient, Standard of care, Risk, Physician, SAN, Illumina, Inc., Division, WGS, Diagnosis, Research, Health, American College, Death, Food, World Health Organization, Pharmaceutical industry, Illumina

SAN DIEGO, April 11, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Henry Ford Health, a not-for-profit health care organization in the Detroit metro area, today announced the launch of a partnership to assess the impact of comprehensive genomic testing in cardiovascular disease. The first study under this new partnership, CardioSeq, launches today and will include 1500 patients receiving care from the Division of Cardiovascular Medicine at Henry Ford.

Key Points: 
  • The first study under this new partnership, CardioSeq, launches today and will include 1500 patients receiving care from the Division of Cardiovascular Medicine at Henry Ford.
  • "This study is the first of several that will measure the impact of whole-genome sequencing in patients with cardiovascular disease," said Dr. David Lanfear , vice president of clinical and translational research at Henry Ford Health and the study's lead clinician.
  • Dr. Phil Febbo, chief medical officer of Illumina, added: "We are honored to partner with Henry Ford Health to assess the potential benefits of integrating genomic testing within specialized care centers in the health care system.
  • The CardioSeq study will use an accredited clinical test developed by Illumina that employs WGS to create a comprehensive cardiovascular genomic profile.

Parsley Health’s Advanced Primary Care is Now In-Network for 10M+ Patients in New York & California

Retrieved on: 
Wednesday, March 29, 2023
Insurance, Women, Hospitals, Fitness & Nutrition, Professional Services, Health Insurance, Family, Managed Care, Consumer, Health, Workforce, Executive, Pregnancy, Autoimmunity, Oscar, Diabetes, B2B, Hospital, Kaiser, Cancer, Henry Ford Health, Woman, Cigna, Incidence, Patient, Risk, Fertility, Menopause, Conditional sentence, Mortality, ROI, Mount Sinai Health System, Health insurance, Nursing, United Freedom Movement, Parsley

Parsley Health , the advanced primary care provider for women and families that uses Root Cause Resolution medicine to drive powerful outcomes and lower costs for patients, today announced that it is in-network for more than 10 million patients across New York and California.

Key Points: 
  • Parsley Health , the advanced primary care provider for women and families that uses Root Cause Resolution medicine to drive powerful outcomes and lower costs for patients, today announced that it is in-network for more than 10 million patients across New York and California.
  • Parsley is now in-network with Aetna CA & Blue Shield CA and a member of Mount Sinai Health System's clinically integrated network.
  • As a result, patients in New York covered by Cigna, Empire BlueCrossBlueShield, Emblem, United Freedom, United Oxford, Oscar, UMR Top Tier, Centivo, Aetna NY and in California covered by Aetna CA and Blue Shield CA can now access Parsley’s personalized primary care in-network.
  • “At Parsley, our mission has always been to close the primary care gap for women and families by making our transformational, advanced primary care as accessible and affordable as possible,” said Dr. Robin Berzin, M.D., Founder and CEO of Parsley Health.

Saranas Reaches Midpoint for Enrollment in Clinical Trial Assessing the Utility of Early Bleed Detection in Patients Undergoing Mechanical Circulatory Support

Retrieved on: 
Monday, March 27, 2023
Cardiology, Surgery, Health, FDA, Medical Devices, Health Technology, Clinical Trials, Other Health, CRF, Bleeding, De novo, Morristown Medical Center, Classification, BARC, Henry Ford Health, Structural heart disease, PCI, Incidence, Henry Ford, Patient, Impella, TAVR, Early Bird, Research, The Early Bird, MCS, Early, EVAR, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, III, Aortic stenosis, Food, Safety, Medical device, Birth control

The Early Bird Bleed Monitoring System is the first and only FDA-approved bleed detection system.

Key Points: 
  • The Early Bird Bleed Monitoring System is the first and only FDA-approved bleed detection system.
  • Patients undergoing complex high-risk PCI with mechanical circulatory support (MCS) via Impella and transfemoral arterial approach are enrolled as study participants.
  • “This is an important milestone in our efforts to continue building clinical evidence to support the utility of the Early Bird device.
  • The Saranas Early Bird Bleed Monitoring System is the first and only FDA-approved device for real-time monitoring of endovascular bleed complications.